{"log_id": 6890653572463294463, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0.000127, "average": 0.995068, "min": 0.939416}, "location": {"width": 784, "top": 135, "height": 46, "left": 208}, "words": "将他克莫司的剂量减至初始剂量的约三分之一。在泊沙康唑治疗期间和停止治疗后应该频繁"}, {"probability": {"variance": 2.6e-05, "average": 0.995865, "min": 0.982881}, "location": {"width": 555, "top": 185, "height": 42, "left": 210}, "words": "监测他克莫司的全血浓度谷值,并且依据此调整他克莫司的剂量"}, {"probability": {"variance": 3.7e-05, "average": 0.9966, "min": 0.965481}, "location": {"width": 738, "top": 225, "height": 47, "left": 254}, "words": "环孢菌素:在开始泊沙康唑治疗后,心脏移植患者的环孢菌素全血浓度升高。建议在开"}, {"probability": {"variance": 0.00042, "average": 0.993108, "min": 0.875559}, "location": {"width": 782, "top": 272, "height": 45, "left": 213}, "words": "始泊沙康唑治疗时,将环孢菌素的剂量减至初始剂量的约四分之三。在泊沙康唑治疗期间和"}, {"probability": {"variance": 2.5e-05, "average": 0.997848, "min": 0.969603}, "location": {"width": 733, "top": 318, "height": 44, "left": 214}, "words": "停止治疗后应该频繁监测环孢菌素的全血浓度谷值,并且依据此调整环孢菌素的剂量"}, {"probability": {"variance": 0.00054, "average": 0.984647, "min": 0.934127}, "location": {"width": 149, "top": 377, "height": 25, "left": 255}, "words": "2、CYP3A4底物"}, {"probability": {"variance": 0.000479, "average": 0.990395, "min": 0.875138}, "location": {"width": 738, "top": 406, "height": 46, "left": 256}, "words": "泊沙康唑与CYP3A4底物,如匹莫齐特和奎尼丁联合用药可导致上述药品的血浆浓度升"}, {"probability": {"variance": 0.000218, "average": 0.994838, "min": 0.910234}, "location": {"width": 781, "top": 452, "height": 47, "left": 219}, "words": "高,从而导致QTc间期延长和罕见的尖端扭转型室性心动过速。因此,禁止泊沙康唑与这些"}, {"probability": {"variance": 4e-06, "average": 0.997632, "min": 0.995485}, "location": {"width": 84, "top": 516, "height": 26, "left": 220}, "words": "药物联用"}, {"probability": {"variance": 0.005128, "average": 0.97897, "min": 0.588638}, "location": {"width": 549, "top": 547, "height": 40, "left": 259}, "words": "3、通过CYP3A4代谢的HMG-CoA还原酶抑制剂(他汀类药物)"}, {"probability": {"variance": 0.001047, "average": 0.990516, "min": 0.798974}, "location": {"width": 744, "top": 587, "height": 45, "left": 262}, "words": "泊沙康唑与辛伐他汀联合用药可导致辛伐他汀血浆浓度约升高10倍。因此,禁止泊沙康"}, {"probability": {"variance": 8e-06, "average": 0.997752, "min": 0.989701}, "location": {"width": 369, "top": 641, "height": 39, "left": 225}, "words": "唑与 hmg-coa还原酶抑制剂辛伐他汀联用"}, {"probability": {"variance": 0.001184, "average": 0.982098, "min": 0.898167}, "location": {"width": 133, "top": 694, "height": 25, "left": 265}, "words": "4、麦角生物残"}, {"probability": {"variance": 0.0131, "average": 0.948555, "min": 0.473141}, "location": {"width": 783, "top": 716, "height": 55, "left": 266}, "words": "大多数麦角生物碱都是CYP3A4底物。泊沙康唑会导致麦角生物碱(麦角相效全角"}, {"probability": {"variance": 0.020441, "average": 0.939916, "min": 0.400046}, "location": {"width": 767, "top": 739, "height": 81, "left": 229}, "words": "胺)血浆浓度升高,可能导致麦角中毒。因此,禁止泊沙康唑与麦角生物碱联用约"}, {"probability": {"variance": 0, "average": 0.7074, "min": 0.7074}, "location": {"width": 25, "top": 753, "height": 27, "left": 988}, "words": "3"}, {"probability": {"variance": 0, "average": 0.918178, "min": 0.918178}, "location": {"width": 29, "top": 797, "height": 27, "left": 1016}, "words": "3"}, {"probability": {"variance": 2.5e-05, "average": 0.994306, "min": 0.98016}, "location": {"width": 348, "top": 823, "height": 35, "left": 265}, "words": "5、通过CYP3A4代谢的苯二氮卓类药物"}, {"probability": {"variance": 0.005567, "average": 0.973695, "min": 0.613751}, "location": {"width": 739, "top": 860, "height": 44, "left": 269}, "words": "泊沙康唑与咪达唑仑联合用药会导致咪达唑仑血浆浓度约升高5倍。而咪达仑血浆浓"}, {"probability": {"variance": 0.005446, "average": 0.980883, "min": 0.534584}, "location": {"width": 778, "top": 907, "height": 42, "left": 233}, "words": "度升高则会增强并且延长催眠和镇静作用。泊沙康唑与其他通过CYP3A4代谢的苯二氮卓类"}, {"probability": {"variance": 0.003773, "average": 0.986361, "min": 0.604683}, "location": {"width": 783, "top": 952, "height": 43, "left": 232}, "words": "药物(例如,阿普唑仑、三唑仑)联合用药会导致这些苯二氮卓类药物血浆浓度升高。必须"}, {"probability": {"variance": 0.000218, "average": 0.994928, "min": 0.908611}, "location": {"width": 780, "top": 996, "height": 44, "left": 232}, "words": "密切监测治疗患者是否发生由于通过CYP3A4代谢的苯二氮卓类药物血浆浓度过高导致的"}, {"probability": {"variance": 0.000593, "average": 0.993388, "min": 0.870857}, "location": {"width": 554, "top": 1045, "height": 40, "left": 234}, "words": "不良反应,并且必须备有苯二氮卓受体拮抗剂用于逆转这些反应"}, {"probability": {"variance": 0.018348, "average": 0.704218, "min": 0.568763}, "location": {"width": 132, "top": 1026, "height": 50, "left": 925}, "words": "辰爽"}, {"probability": {"variance": 0.003069, "average": 0.970692, "min": 0.830055}, "location": {"width": 129, "top": 1101, "height": 24, "left": 275}, "words": "6、抗HIV药物"}, {"probability": {"variance": 0.002486, "average": 0.98098, "min": 0.709721}, "location": {"width": 738, "top": 1133, "height": 40, "left": 276}, "words": "依法书仑:依法韦仑可诱导UDP葡糖苷酶,并且显著降低泊沙康唑血浆浓度。除非获"}, {"probability": {"variance": 2.1e-05, "average": 0.99835, "min": 0.977356}, "location": {"width": 456, "top": 1183, "height": 36, "left": 236}, "words": "益超过风险,否则推荐避免依法韦仑与泊沙康唑联用"}, {"probability": {"variance": 6.4e-05, "average": 0.995122, "min": 0.961152}, "location": {"width": 739, "top": 1223, "height": 40, "left": 277}, "words": "利托那韦和阿扎那韦:利托那韦和阿扎那韦通过CYP3A4代谢,而泊沙康唑会导致这些"}, {"probability": {"variance": 1.7e-05, "average": 0.997713, "min": 0.981801}, "location": {"width": 775, "top": 1267, "height": 43, "left": 243}, "words": "药物的血浆浓度升高。在与泊沙康唑联合使用期间,应该频繁监测不良反应和毒性,并且对"}, {"probability": {"variance": 1.8e-05, "average": 0.99717, "min": 0.982289}, "location": {"width": 297, "top": 1322, "height": 31, "left": 241}, "words": "利托那韦和阿扎那韦进行剂量调整"}, {"probability": {"variance": 0.000672, "average": 0.984145, "min": 0.927953}, "location": {"width": 113, "top": 1370, "height": 26, "left": 278}, "words": "7、利福布汀"}, {"probability": {"variance": 0.00757, "average": 0.969634, "min": 0.603725}, "location": {"width": 731, "top": 1403, "height": 40, "left": 283}, "words": "利福布汀可诱导UDP-葡糖苷酶,并且降低泊沙康唑血浆浓度。利福布汀也通过CYP3A"}, {"probability": {"variance": 3.4e-05, "average": 0.996803, "min": 0.967023}, "location": {"width": 777, "top": 1449, "height": 38, "left": 244}, "words": "代谢。因此,利福布汀与泊沙康唑联合用药会导致利福布汀血浆浓度升高。除非对患者的获"}, {"probability": {"variance": 0, "average": 0.92075, "min": 0.92075}, "location": {"width": 71, "top": 1479, "height": 32, "left": 1027}, "words": "沙"}], "language": 3}